Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiling Yan

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Bioresource Technology|November 26, 2023
Rice husk hydrochar prepared by hydrochloric acid assisted hydrothermal carbonization for levofloxacin removal in bioretention columnsYidan Luo, Yuanwang Lan, Shuzhen Liang, et al.
Cell Death Discovery|May 10, 2022
Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy miceMeiling Yan, Yun Li, Qingmao Luo, et al.
Experimental Cell Research|May 11, 2019
Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17Meiling Yan, Kankai Chen, Rong Sun, et al.
Experimental Cell Research|September 19, 2020
Corrigendum to "Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17" [Exp. Cell Res. 381 (2019) 191-200]Meiling Yan, Kankai Chen, Rong Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2026
Corrigendum "The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice" [Biomed. Pharmacother. 164 (2023) 114919]Meiling Yan, Suping Liu, Wenru Zeng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2023
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic miceMeiling Yan, Suping Liu, Wenru Zeng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 19, 2022
FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathwayYue Zhang, Mengxian Sun, Dongwei Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 17, 2022
Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte PyroptosisXiaoqi Shao, Bingying Huang, Huiling Tan, et al.
Journal of Ethnopharmacology|January 14, 2024
Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaquesXiaoqi Shao, Wenru Zeng, Qing Wang, et al.
Pharmacological Research|February 12, 2022
MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2Yue Zhang, Zhiying Wang, Dingming Lan, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Bioresource Technology|November 26, 2023
Rice husk hydrochar prepared by hydrochloric acid assisted hydrothermal carbonization for levofloxacin removal in bioretention columnsYidan Luo, Yuanwang Lan, Shuzhen Liang, et al.
Cell Death Discovery|May 10, 2022
Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy miceMeiling Yan, Yun Li, Qingmao Luo, et al.
Experimental Cell Research|May 11, 2019
Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17Meiling Yan, Kankai Chen, Rong Sun, et al.
Experimental Cell Research|September 19, 2020
Corrigendum to "Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17" [Exp. Cell Res. 381 (2019) 191-200]Meiling Yan, Kankai Chen, Rong Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2026
Corrigendum "The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice" [Biomed. Pharmacother. 164 (2023) 114919]Meiling Yan, Suping Liu, Wenru Zeng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2023
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic miceMeiling Yan, Suping Liu, Wenru Zeng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 19, 2022
FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathwayYue Zhang, Mengxian Sun, Dongwei Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 17, 2022
Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte PyroptosisXiaoqi Shao, Bingying Huang, Huiling Tan, et al.
Journal of Ethnopharmacology|January 14, 2024
Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaquesXiaoqi Shao, Wenru Zeng, Qing Wang, et al.
Pharmacological Research|February 12, 2022
MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2Yue Zhang, Zhiying Wang, Dingming Lan, et al.
Pageof 8